SO
VTAE

STRS Ohio’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

STRS Ohio’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-18,933
Closed -$204K – 2007
2016
Q2 		$204K Hold
18,933
– – ﹤0.01% 1547
2016
Q1 		$125K Hold
18,933
– – ﹤0.01% 1612
2015
Q4 		$342K Hold
18,933
– – ﹤0.01% 1400
2015
Q3 		$208K Buy
18,933
+17,033
+896% +$181K ﹤0.01% 1514
2015
Q2 		$27K Hold
1,900
– – ﹤0.01% 1806
2015
Q1 		$22K Hold
1,900
– – ﹤0.01% 1758
2014
Q4 		$32K Buy
+1,900
New +$27.8K ﹤0.01% 1656

Other funds holding VTAE

AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

STRS Ohio's VTAE Position: Q3 2016 in Review

STRS Ohio sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q3 2016, closing a stake of 18,933 shares — an estimated $204K sold.

STRS Ohio first reported a position in VTAE in Q4 2014 and held it in 7 quarters. The position peaked at $342K in Q4 2015. 98 funds tracked by Wall St. Rank hold VTAE as of Q3 2016.

  • STRS Ohio reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • STRS Ohio sold 18,933 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q3 2016, an estimated $204K.
  • STRS Ohio first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 7 quarters.
  • STRS Ohio's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $342K in Q4 2015.
  • 98 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q3 2016.

Based on STRS Ohio's 13F filing for Q3 2016, filed 27 Oct 2016.